Market Overview

Trade CNS stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

DateResearch FirmActionCurrentTarget
7/20/18Credit SuisseMaintainsNeutralNeutral41.0
4/16/18Gabelli & Co.UpgradesHoldBuy
1/26/18Keefe Bruyette & WoodsDowngradesMarket PerformUnderperform
Show more Loading articles...

Earnings View Earnings

Q3 2018 EST Actual Surprise
EPS: 0.62 0.64 0.02
Rev: 98.15M 98.33M 181.00K
Q4 2018 EST Actual Surprise
EPS: Expected
2019-01-23
Rev:

Company Profile